Home › Metastatic Cancer › Indiana › Fort Wayne
Metastatic Cancer clinical trials in Fort Wayne, IN
6 studies for Metastatic Cancer are looking for participants at sites in and around Fort Wayne (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
RecruitingPhase 3
- Research Site, Fort Wayne
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RecruitingPhase 3
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Fort Wayne
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RecruitingPhase 3
- Parkview Packnett Family Cancer Institute, Fort Wayne
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RecruitingPhase 1/2
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Fort Wayne
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer8 studies
- Breast Cancer7 studies
- Chronic Lymphocytic Leukemia7 studies
- Cancer (all types)7 studies
- Lung Cancer6 studies
- Endometrial Cancer5 studies
- Triple-Negative Breast Cancer4 studies
- Multiple Myeloma4 studies
- Bladder Cancer4 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Melanoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.